Significant drug interaction is now being reported between oral contraceptives and Rezulin (troglitazone)

    A significant drug interaction is now being reported between oral contraceptives and Rezulin (troglitazone).

    Rezulin is the brand new diabetes drug from Parke-Davis. It just came out in the U.S...and will be launched soon in Canada. Rezulin increases insulin sensitivity in type 2 diabetics.

    The problem is that Rezulin is an enzyme inducer...similar to phenobarbital and other anticonvulsants.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote